TIGIT and cancer: For example, the dysregulation of the IR TIGIT and CD226 (a stimulatory receptor that shares CD112 and CD155 ligands with TIGIT) expression in T cells was recently suspected to be involved in severe forms of autoimmune diseases17,18, as well as in cancer and chronic viral infections19–21.